Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

RXL vs. RYHIX: which is better?

Bottom line

RXL vs RYHIX: the short answer

RXL (ProShares Ultra Health Care) and RYHIX (Health Care Fund) are both etfs.

RXL is cheaper at 0.95% vs 1.38% — a difference of $43 a year per $10,000 invested.

Over five years, RXL returned +7.2% a year vs +5.1% for RYHIX.

Updated Nov 19, 2026

RXL vs RYHIX side by side

RXLRYHIX
TypeETFMutual fund
Fund familyProSharesGuggenheim
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.95%1.38%
Annual cost per $10k$95$138
10-yr cost on $10k (prospectus)$1,305$1,709
Max front loadNone—
12b-1 fee—0%
1-yr return+19.7%+14.4%
5-yr return (annualized)+7.2%+5.1%
10-yr return (annualized)+12.6%+7.9%
Best quarter+29.7%+18.7%
Worst quarter−28.9%−14.4%
Net assets (fund)$72.1M$19.4M
Number of holdings70135
Portfolio turnover4%244%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearRXLRYHIXDifference
2025+19.7%+14.4%+5.2%
2024−2.7%+0.6%−3.3%
2023−3.2%+5.8%−9.0%
2022−15.1%−11.6%−3.5%
2021+47.8%+19.2%+28.6%
2020+19.2%+18.9%+0.3%
2019+38.9%+22.8%+16.1%
2018+5.4%+1.6%+3.8%
2017+46.0%+23.5%+22.5%
2016−8.9%−9.4%+0.4%

Source: Fund prospectus bar charts

Holdings overlap

20 of RXL's top 25 holdings also appear in RYHIX's top 25.

Shared top holdings
HoldingRXLRYHIX
Eli Lilly & Co.12.67%3.63%
Johnson & Johnson7.86%2.88%
AbbVie, Inc.5.57%2.52%
UnitedHealth Group, Inc.4.98%2.22%
Merck & Co., Inc.4.26%2.04%
Thermo Fisher Scientific, Inc.2.68%1.61%
Amgen, Inc.2.62%1.56%
Gilead Sciences, Inc.2.41%1.39%
Intuitive Surgical, Inc.2.18%1.31%
Pfizer, Inc.2.15%1.25%
Abbott Laboratories2.15%1.42%
Bristol-Myers Squibb Co.1.68%1.22%
CVS Health Corp.1.67%1.31%
Danaher Corp.1.66%1.30%
Vertex Pharmaceuticals, Inc.1.64%1.34%

Source: SEC Form N-PORT

RXL top 10

  1. Eli Lilly & Co. — 12.67%
  2. ProShares GENIUS Money Market ETF — 11.81%
  3. Johnson & Johnson — 7.86%
  4. AbbVie, Inc. — 5.57%
  5. UnitedHealth Group, Inc. — 4.98%
  6. Merck & Co., Inc. — 4.26%
  7. Repurchase Agreement — 2.91%
  8. Thermo Fisher Scientific, Inc. — 2.68%
  9. Amgen, Inc. — 2.62%
  10. Gilead Sciences, Inc. — 2.41%

RYHIX top 10

  1. Eli Lilly & Company — 3.63%
  2. Johnson & Johnson — 2.88%
  3. Abbvie Inc — 2.52%
  4. Unitedhealth Group Inc — 2.22%
  5. Merck & Company Inc — 2.04%
  6. Thermo Fisher Scientific Inc — 1.61%
  7. Amgen Inc — 1.56%
  8. Abbott Laboratories — 1.42%
  9. Gilead Sciences Inc — 1.39%
  10. Vertex Pharmaceuticals Inc — 1.34%

FAQ

What is the difference between RXL and RYHIX?
RXL (ProShares Ultra Health Care) and RYHIX (Health Care Fund) are both etfs. RXL is cheaper at 0.95% vs 1.38% — a difference of $43 a year per $10,000 invested.
Which is cheaper, RXL or RYHIX?
RXL has the lower expense ratio (0.95%).
Should I own both RXL and RYHIX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.